IBDEI1QH ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30668,1,4,0)
 ;;=4^N84.1
 ;;^UTILITY(U,$J,358.3,30668,2)
 ;;=^5015866
 ;;^UTILITY(U,$J,358.3,30669,0)
 ;;=N94.1^^178^1924^40
 ;;^UTILITY(U,$J,358.3,30669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30669,1,3,0)
 ;;=3^Dyspareunia
 ;;^UTILITY(U,$J,358.3,30669,1,4,0)
 ;;=4^N94.1
 ;;^UTILITY(U,$J,358.3,30669,2)
 ;;=^5015917
 ;;^UTILITY(U,$J,358.3,30670,0)
 ;;=N94.6^^178^1924^39
 ;;^UTILITY(U,$J,358.3,30670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30670,1,3,0)
 ;;=3^Dysmenorrhea, unspecified
 ;;^UTILITY(U,$J,358.3,30670,1,4,0)
 ;;=4^N94.6
 ;;^UTILITY(U,$J,358.3,30670,2)
 ;;=^5015922
 ;;^UTILITY(U,$J,358.3,30671,0)
 ;;=N39.3^^178^1924^93
 ;;^UTILITY(U,$J,358.3,30671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30671,1,3,0)
 ;;=3^Stress incontinence (female) (male)
 ;;^UTILITY(U,$J,358.3,30671,1,4,0)
 ;;=4^N39.3
 ;;^UTILITY(U,$J,358.3,30671,2)
 ;;=^5015679
 ;;^UTILITY(U,$J,358.3,30672,0)
 ;;=R10.2^^178^1924^76
 ;;^UTILITY(U,$J,358.3,30672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30672,1,3,0)
 ;;=3^Pelvic and perineal pain
 ;;^UTILITY(U,$J,358.3,30672,1,4,0)
 ;;=4^R10.2
 ;;^UTILITY(U,$J,358.3,30672,2)
 ;;=^5019209
 ;;^UTILITY(U,$J,358.3,30673,0)
 ;;=N91.2^^178^1924^15
 ;;^UTILITY(U,$J,358.3,30673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30673,1,3,0)
 ;;=3^Amenorrhea, unspecified
 ;;^UTILITY(U,$J,358.3,30673,1,4,0)
 ;;=4^N91.2
 ;;^UTILITY(U,$J,358.3,30673,2)
 ;;=^5015904
 ;;^UTILITY(U,$J,358.3,30674,0)
 ;;=N92.0^^178^1924^47
 ;;^UTILITY(U,$J,358.3,30674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30674,1,3,0)
 ;;=3^Excessive and frequent menstruation with regular cycle
 ;;^UTILITY(U,$J,358.3,30674,1,4,0)
 ;;=4^N92.0
 ;;^UTILITY(U,$J,358.3,30674,2)
 ;;=^5015908
 ;;^UTILITY(U,$J,358.3,30675,0)
 ;;=N92.1^^178^1924^48
 ;;^UTILITY(U,$J,358.3,30675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30675,1,3,0)
 ;;=3^Excessive and frequent menstruation with irregular cycle
 ;;^UTILITY(U,$J,358.3,30675,1,4,0)
 ;;=4^N92.1
 ;;^UTILITY(U,$J,358.3,30675,2)
 ;;=^5015909
 ;;^UTILITY(U,$J,358.3,30676,0)
 ;;=N93.0^^178^1924^81
 ;;^UTILITY(U,$J,358.3,30676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30676,1,3,0)
 ;;=3^Postcoital and contact bleeding
 ;;^UTILITY(U,$J,358.3,30676,1,4,0)
 ;;=4^N93.0
 ;;^UTILITY(U,$J,358.3,30676,2)
 ;;=^5015914
 ;;^UTILITY(U,$J,358.3,30677,0)
 ;;=N93.8^^178^1924^4
 ;;^UTILITY(U,$J,358.3,30677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30677,1,3,0)
 ;;=3^Abnormal uterine and vaginal bleeding
 ;;^UTILITY(U,$J,358.3,30677,1,4,0)
 ;;=4^N93.8
 ;;^UTILITY(U,$J,358.3,30677,2)
 ;;=^5015915
 ;;^UTILITY(U,$J,358.3,30678,0)
 ;;=N92.4^^178^1924^49
 ;;^UTILITY(U,$J,358.3,30678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30678,1,3,0)
 ;;=3^Excessive bleeding in the premenopausal period
 ;;^UTILITY(U,$J,358.3,30678,1,4,0)
 ;;=4^N92.4
 ;;^UTILITY(U,$J,358.3,30678,2)
 ;;=^5015911
 ;;^UTILITY(U,$J,358.3,30679,0)
 ;;=N95.0^^178^1924^83
 ;;^UTILITY(U,$J,358.3,30679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30679,1,3,0)
 ;;=3^Postmenopausal bleeding
 ;;^UTILITY(U,$J,358.3,30679,1,4,0)
 ;;=4^N95.0
 ;;^UTILITY(U,$J,358.3,30679,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,30680,0)
 ;;=N95.1^^178^1924^71
 ;;^UTILITY(U,$J,358.3,30680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30680,1,3,0)
 ;;=3^Menopausal and female climacteric states
 ;;^UTILITY(U,$J,358.3,30680,1,4,0)
 ;;=4^N95.1
 ;;^UTILITY(U,$J,358.3,30680,2)
 ;;=^5015927
 ;;^UTILITY(U,$J,358.3,30681,0)
 ;;=N95.2^^178^1924^82
 ;;^UTILITY(U,$J,358.3,30681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30681,1,3,0)
 ;;=3^Postmenopausal atrophic vaginitis
 ;;
 ;;$END ROU IBDEI1QH
